Blue Dye 2 vs Sodium Nitrite: which is worse?

What is Blue Dye 2?

Blue Dye 2 (Indigotine/Indigo Carmine) is a synthetic disulfonated derivative of indigo. Unlike natural indigo from the indigo plant, the FD&C version is synthetically manufactured from petroleum. It produces a dark royal blue to indigo color and is used in food, pharmaceuticals, and medical diagnostics.

What is Sodium Nitrite?

Sodium nitrite (NaNO2) is a salt and food additive used as a preservative, color fixative, and curing agent in processed meats. It gives cured meats (bacon, hot dogs, ham) their characteristic pink color and prevents the growth of Clostridium botulinum bacteria that cause botulism.

Documented risks

Blue Dye 2: Animal studies conducted in the 1980s found that high-dose Blue Dye 2 caused brain tumors in male rats. An NTP bioassay (1987) found statistically significant increases in brain gliomas (astrocytomas) in male rats given high doses. The FDA reviewed these findings and determined that the doses far exceeded typical human dietary exposure. Nonetheless, the tumor finding remains in the scientific record as a concerning data point. EFSA's 2010 safety evaluation of Indigo Carmine (E132) reached an unusual conclusion: it could not establish an ADI due to data limitations, including the brain tumor findings. This means EFSA adopted an implicit conservative position — it neither declared Blue 2 safe nor formally banned it, but the absence of an established ADI signals scientific uncertainty. In medical diagnostic use, high intravenous doses of Indigo Carmine can cause hypertension, bradycardia, and in rare cases anaphylaxis. These are dose-specific clinical pharmacological effects, not relevant to dietary consumption at food use levels. Blue 2 was not included in the 2007 Lancet hyperactivity study. Limited direct research links Blue 2 to behavioral effects. The FDA's April 2025 announcement includes Blue 2 in the class of petroleum-based synthetic dyes to be phased out of the US food supply, reflecting updated policy on the category rather than specific new Blue 2 toxicity data.

Sodium Nitrite: Sodium nitrite's primary health concern is the formation of nitrosamines. Under cooking heat or in the acidic environment of the stomach, nitrite can react with secondary amines (found in protein-rich foods) to form N-nitrosamines — a class of potent carcinogens. Several N-nitrosamines are classified as Group 1 or Group 2A carcinogens by IARC. The association between processed meat consumption and colorectal cancer is well established. IARC classified processed meat (including nitrite-cured meats like bacon, hot dogs, and ham) as a Group 1 human carcinogen in 2015, citing sufficient evidence from epidemiological studies. A comprehensive meta-analysis found that each 50g/day increase in processed meat consumption was associated with an 18% increase in colorectal cancer risk. Nitrite can also be converted to nitric oxide (NO) in the body, which at high doses can oxidize hemoglobin to methemoglobin — a condition called methemoglobinemia (or 'blue baby syndrome') that impairs oxygen transport. This is particularly dangerous for infants, which is why baby food with added nitrite is banned across the EU. However, many experts argue that the actual dietary cancer risk from nitrite in cured meats is difficult to separate from other components of processed meat (saturated fat, heme iron, cooking methods like smoking and charring) that also generate carcinogenic compounds. The paradox of nitrite regulation: the FDA requires it in some meat products for botulism prevention — making total elimination potentially more dangerous than restricted use. The focus of public health guidance is reducing consumption of processed meats, not eliminating nitrite entirely.